Novo Nordisk and US biotech company team up to create obesity pills

by

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases.

Leave A Comment

Your email address will not be published. Required fields are marked *